| scholarly article | Q13442814 |
| P50 | author | Claire M. Williams | Q42981147 |
| P2093 | author name string | Rogers PJ | |
| Kirkham TC | |||
| P2860 | cites work | Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of delta9-tetrahydrocannabinol | Q67583231 |
| Comparative effects of various naturally occurring cannabinoids on food, sucrose and water consumption by rats | Q67781065 | ||
| Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats | Q70813698 | ||
| Prefeeding potentiates anorectic actions of neuromedin B and gastrin releasing peptide | Q71061972 | ||
| Hunger and appetite after single doses of marihuana, alcohol, and dextroamphetamine | Q71751539 | ||
| Cannabinoids and appetite stimulation | Q72397970 | ||
| Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| Cannabis: Effects on hunger and thirst | Q34076824 | ||
| Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra | Q34421920 | ||
| Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis | Q34631075 | ||
| Delta-9-tetrahydrocannabinol (THC) fails to stimulate consumption of a highly palatable food in the rat. | Q40868058 | ||
| Modulation of rat brain cannabinoid receptors after chronic morphine treatment | Q42546895 | ||
| Attenuation of sham feeding by naloxone is stereospecific: evidence for opioid mediation of orosensory reward | Q44343746 | ||
| delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors | Q44345904 | ||
| Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism | Q44346123 | ||
| Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. | Q47360477 | ||
| Naloxone attenuation of sham feeding is modified by manipulation of sucrose concentration | Q48162737 | ||
| Neuropeptide Y attenuates satiety: evidence from a detailed analysis of patterns ingestion | Q48175622 | ||
| Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors | Q48664473 | ||
| Effect of fourth ventricular neuropeptide Y and peptide YY on ingestive and other behaviors | Q48921348 | ||
| Effects of marihuana on the solution of anagrams, memory and appetite. | Q52260992 | ||
| Effects of delta9-THC on food and water intake of deprivation experienced rats. | Q52978208 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 343-346 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | Physiology & Behavior | Q3618986 |
| P1476 | title | Hyperphagia in pre-fed rats following oral delta9-THC. | |
| P478 | volume | 65 |
| Q48113599 | A clozapine-like effect of cyproheptadine on progressive ratio schedule performance |
| Q48408917 | A comparison of the effects of the CB(1) receptor antagonist SR141716A, pre-feeding and changed palatability on the microstructure of ingestive behaviour. |
| Q33429531 | A cost-effective high-throughput digital system for observation and acquisition of animal behavioral data |
| Q44205907 | A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. |
| Q58370813 | A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men |
| Q41961347 | A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents |
| Q45079498 | Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC. |
| Q43267773 | Anandamide and AM251, via water, modulate food intake at central and peripheral level in fish |
| Q44318882 | Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice |
| Q37336601 | Blockade of the endocannabinoid system for the reduction of cardiometabolic risk factors |
| Q62274533 | Body mass index across adolescence and substance use problems in early adulthood |
| Q35048878 | CB1 cannabinoid receptor-mediated modulation of food intake in mice |
| Q37998561 | CB1 receptor antagonists: new discoveries leading to new perspectives |
| Q33293362 | CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health |
| Q39509962 | Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats |
| Q36830438 | Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions |
| Q24602175 | Cannabinoid facilitation of behavioral and biochemical hedonic taste responses |
| Q21090468 | Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far |
| Q37444818 | Cannabinoids and appetite: food craving and food pleasure |
| Q36977777 | Cannabinoids in eating disorders and obesity |
| Q30357350 | Cannabinoids, eating behaviour, and energy homeostasis. |
| Q39623454 | Cannabinol and cannabidiol exert opposing effects on rat feeding patterns |
| Q34618296 | Cannabis constituents modulate δ9-tetrahydrocannabinol-induced hyperphagia in rats |
| Q37826693 | Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation |
| Q58557888 | Combined ∆-tetrahydrocannabinol and moderate alcohol administration: effects on ingestive behaviors in adolescent male rats |
| Q43653896 | Critical role of the endogenous cannabinoid system in mouse pup suckling and growth |
| Q36579590 | Current and novel approaches to the drug therapy of obesity |
| Q43590238 | Delta(9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets |
| Q45407578 | Delta-9-tetrahydrocannabinol enhances food reinforcement in a mouse operant conflict test |
| Q36335488 | Dissociable effects of the cannabinoid receptor agonists Δ9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats |
| Q48470538 | Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food? |
| Q36201313 | Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats |
| Q52541827 | Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding. |
| Q48357703 | Effects of the cannabinoid antagonists AM281 and AM630 on deprivation-induced intake in Lewis rats |
| Q47243602 | Effects of the cannabinoid receptor agonist, HU 210, on ingestive behaviour and body weight of rats |
| Q39400299 | Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling |
| Q36108722 | Endocannabinoid control of food intake and energy balance |
| Q34003324 | Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward |
| Q42981075 | Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol |
| Q48306103 | Endocannabinoids and the Non-Homeostatic Control of Appetite |
| Q88924595 | Endocannabinoids in Body Weight Control |
| Q61479731 | Endogenous cannabinoid system as a modulator of food intake |
| Q44279121 | Endogenous cannabinoids: a new target in the treatment of obesity |
| Q91801377 | Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa |
| Q36392903 | Estradiol signaling in the regulation of reproduction and energy balance |
| Q42151441 | Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism |
| Q51980585 | Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats. |
| Q26783258 | Growth Hormone Secretagogue Receptor Dimers: A New Pharmacological Target(1,2,3) |
| Q34320139 | Hu 210: a potent tool for investigations of the cannabinoid system. |
| Q28190374 | Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716 |
| Q46619350 | Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. |
| Q46107799 | Influence of intracerebroventricular or intraperitoneal administration of cannabinoid receptor agonist (WIN 55,212-2) and inverse agonist (AM 251) on the regulation of food intake and hypothalamic serotonin levels |
| Q92709700 | Joint and separate exposure to alcohol and ∆9-tetrahydrocannabinol produced distinct effects on glucose and insulin homeostasis in male rats |
| Q41921763 | MRAP2 regulates ghrelin receptor signaling and hunger sensing. |
| Q34173626 | Marijuana-based drugs: innovative therapeutics or designer drugs of abuse? |
| Q44094153 | Memory impairment following combined exposure to delta(9)-tetrahydrocannabinol and ethanol in rats |
| Q36097577 | Mice Expressing a "Hyper-Sensitive" Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor Diabetic |
| Q36477132 | Midbrain response to milkshake correlates with ad libitum milkshake intake in the absence of hunger |
| Q44348590 | Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems |
| Q37352232 | Neuroendocrine and physiological regulation of intake with particular reference to domesticated ruminant animals |
| Q47636194 | Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea |
| Q36110584 | Noladin ether, a putative endocannabinoid, enhances motivation to eat after acute systemic administration in rats |
| Q92627340 | Opportunities for cannabis in supportive care in cancer |
| Q41229463 | Oral Administration of the Endocannabinoid Anandamide during Lactation: Effects on Hypothalamic Cannabinoid Type 1 Receptor and Food Intake in Adult Mice. |
| Q38135917 | PUFA-derived endocannabinoids: an overview |
| Q36753785 | Peripheral tissue-brain interactions in the regulation of food intake |
| Q93147542 | Preclinical and Clinical Evidence for a Distinct Regulation of Mu Opioid and Type 1 Cannabinoid Receptor Genes Expression in Obesity |
| Q44359168 | Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. |
| Q40700671 | Pregnenolone can protect the brain from cannabis intoxication |
| Q35946981 | Quantitative analysis of performance on a progressive-ratio schedule: effects of reinforcer type, food deprivation and acute treatment with Δ⁹-tetrahydrocannabinol (THC) |
| Q36985061 | Receptor subtypes and signal transduction mechanisms contributing to the estrogenic attenuation of cannabinoid-induced changes in energy homeostasis |
| Q35834277 | Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota |
| Q43867297 | Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine |
| Q36070972 | Rimonabant abolishes sensitivity to workload changes in a progressive ratio procedure. |
| Q36030335 | Role of systemic endocannabinoid CB-1 receptor antagonism in the acquisition and expression of fructose-conditioned flavor-flavor preferences in rats |
| Q60155183 | Role of the superior colliculus in the motor effects of cannabinoids and dopamine |
| Q36650335 | Structural analogs of pyrazole and sulfonamide cannabinoids: effects on acute food intake in mice |
| Q41428934 | Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice |
| Q33960904 | Tetrahydrocannabinol and endocannabinoids in feeding and appetite |
| Q34222264 | The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats. |
| Q43262077 | The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin. |
| Q44407253 | The cannabinoid receptor antagonist SR�141716 attenuates overfeeding induced by systemic or intracranial morphine |
| Q35226232 | The cannabinoid system: a role in both the homeostatic and hedonic control of eating? |
| Q37441554 | The effects of Δ9-tetrahydrocannabinol on the dopamine system. |
| Q38220568 | The endocannabinoid system and appetite: relevance for food reward |
| Q24648473 | The endocannabinoid system as an emerging target of pharmacotherapy |
| Q36741861 | The endocannabinoid system in brain reward processes |
| Q35169067 | The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis |
| Q35459617 | The role of gastrointestinal vagal afferent fibres in obesity |
| Q40397521 | The type-1 cannabinoid receptor modulates the hydroelectrolytic balance independently of the energy homeostasis during salt load. |
| Q91286985 | Vapor Cannabis Exposure Promotes Genetic Plasticity in the Rat Hypothalamus |
Search more.